CDO1 and gastric cancer: Additionally, the overall survival (OS) rate in patients with GC was analyzed, showing that these patients with lower CDO1 level were susceptible to poorer survival (N = 130; median OS: high, 45 months vs. low, 29 months; p < 0.001) (Fig. 1E).